ArticleOncology letters2022

Prophylaxis of cancer-associated venous thromboembolism with low-molecular-weight heparin-tinzaparin: Real world evidence.

Athina Christopoulou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.